🇰🇷 Bludigo in South Korea

Bludigo (Indigo carmine) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Bludigo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Nephrology approved in South Korea

Frequently asked questions

Is Bludigo approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Bludigo in South Korea?

Provepharm Sas is the originator. The local marketing authorisation holder may differ — check the official source linked above.